Feinberg, Konstantin <br/><br/>
A neuroprotective agent that inactivates prodegenerative TrkA and preserves mitochondria.  [electronic resource] 

 -  The Journal of cell biology  11 2017 
 - 3655-3675 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1540-8140 
<br/><br/><label>Standard No.: </label>10.1083/jcb.201705085  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic Fibers--drug effects<br/>Anilides--pharmacology<br/>Animals<br/>Apoptosis--drug effects<br/>Apoptosis Regulatory Proteins--genetics<br/>Axons--drug effects<br/>Cells, Cultured<br/>Crush Injuries--drug therapy<br/>Cytoprotection<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Genotype<br/>Mice, Inbred C57BL<br/>Mice, Transgenic<br/>Mitochondria--drug effects<br/>Motor Neurons--drug effects<br/>Mutation<br/>Neurons--drug effects<br/>Neuroprotective Agents--pharmacology<br/>Phenotype<br/>Phosphorylation<br/>Protein Kinase Inhibitors--pharmacology<br/>Quinolines--pharmacology<br/>Rats, Sprague-Dawley<br/>Receptor, trkA--antagonists & inhibitors<br/>Sciatic Nerve--drug effects<br/>Sciatic Neuropathy--drug therapy<br/>Sensory Receptor Cells--drug effects<br/>Signal Transduction<br/>Superoxide Dismutase-1--genetics<br/>Time Factors<br/>Transcription, Genetic<br/>Wallerian Degeneration